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Abstract
Airway allergen exposure induces inflammation among
individuals with atopy that is characterized by altered airway gene
expression, elevated levels of T helper type 2 cytokines, mucus
hypersecretion, and airflow obstruction. To identify the genetic
determinants of the airway allergen response, we employed
a systems genetics approach. We applied a house dust mite mouse
model of allergic airway disease to 151 incipient lines of the
Collaborative Cross, a new mouse genetic reference population,
andmeasured serum IgE, airway eosinophilia, and gene expression
in the lung. Allergen-induced serum IgE and airway eosinophilia
were not correlated. We detected quantitative trait loci (QTL) for
airway eosinophilia on chromosome (Chr) 11 (71.802–87.098
megabases [Mb]) and allergen-induced IgE on Chr 4 (13.950–
31.660 Mb). More than 4,500 genes expressed in the lung had gene
expression QTL (eQTL), the majority of which were located near
the gene itself. However, we also detected approximately 1,700
trans-eQTL, and many of these trans-eQTL clustered into two
regions on Chr 2. We show that one of these loci (at 147.6 Mb) is
associated with the expression of more than 100 genes, and, using
bioinformatics resources, fine-map this locus to a 53 kb-long
interval.We also use the gene expression and eQTL data to identify
a candidate gene, Tlcd2, for the eosinophil QTL. Our results
demonstrate that hallmark allergic airway disease phenotypes are
associated with distinct genetic loci on Chrs 4 and 11, and that gene
expression in the allergically inflamed lung is controlled by both
cis and trans regulatory factors.
Keywords: allergic airway disease; systems genetics; gene
expression quantitative trait loci
Clinical Relevance
Using a systems genetics approach and a new mouse genetics
reference population, we examined correlations between key
features of allergic inflammation, namely IgE and airway
eosinophilia, and identified distinct genetic loci associated with
each trait. We show that the expression of many genes
(. 4,500) in the lung after allergen challenge is also under
genetic control, in part by distal regulatory factors. These gene
expression data provide insight about gene regulation in the
context of allergen challenge, and also point to a novel
candidate gene for allergic inflammation.
The prevalence of allergic airway diseases
(AADs), including asthma and allergic
rhinitis, has increased dramatically over the
last 50 years, especially in more developed
countries (1). These diseases affect some
8–16% of the population in the United
States, and cause substantial decrements in
quality of life and productivity (2–4).
Hallmark phenotypes of AAD include
elevated serum IgE, airway eosinophilia,
and mucus hypersecretion. The etiology
of AAD remains enigmatic and complex,
and likely involves complex interactions
between genes and environment (5–8).
Genome-wide association studies in
humans have identified several loci
associated with asthma in multiple study
populations (9–14), and a genome-wide
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association study of allergic rhinitis also
identified multiple loci, some of which
overlap with asthma loci (e.g., LRRC32,
HLA-G, and TSLP) (15). Several studies
have also identified gene expression profiles
that differentiate normal versus AAD
in affected tissue (16–21).
We set out to expand on existing
knowledge of the genetics and
transcriptomics of AAD using a systems
genetics approach. To accomplish this, we
applied a house dust mite (HDM) mouse
model of AAD in the lung (22) to incipient
lines of the Collaborative Cross (CC). The
CC is composed of a panel of recombinant
inbred lines derived from eight-way crosses
using five classical inbred strains (C57BL/6J,
129S1/SvImJ, A/J, NOD/ShiLtJ, and NZO/
HlLtJ) and three wild-derived inbred strains
(WSB/EiJ, PWK/PhJ, and CAST/EiJ) (23),
the genomes of which have recently been
sequenced (24, 25). Quantitative trait loci
(QTL) for many traits have been identified
using these incipient CC lines (26–29),
which we refer to as “preCC” mice.
In the present work, we report on
four types of correlations: between AAD
phenotypes, between genotype and AAD
phenotypes (i.e., QTL), between gene
expression and AAD phenotype, and
between genotype and gene expression
(expression QTL or “eQTL”). We focused
much of our work on eQTL discovery
in the allergen-challenged mouse lung,
because genetically determined variation in
gene expression is thought to contribute to
asthma (31, 32), and this has not yet been
examined in a mouse model of AAD.
Materials and Methods
Additional details about methods are
provided in the online supplement.
Mice
We obtained 151 male preCC mice from
Oak Ridge National Laboratory (Oak Ridge,
TN). Each mouse was from a distinct CC
line that had undergone 5–14 generations of
inbreeding. All mice were singly housed
with a-dri bedding and fed NIH-31
Open Formula mouse sterilized diet in
an Association for Assessment and
Accreditation of Laboratory Animal Care–
approved facility at the National Institutes
of Health (Bethesda, MD) under normal
12-hour light/dark cycles.
Phenotyping Protocol
We adapted our model of HDM-induced
AAD (22) to a longitudinal study design in
which preCC mice were phenotyped at two
different time points, baseline and final, as
follows. On Day 9 of the study, we took
serum samples from 8- to 12-week-old
preCC mice for baseline measurements of
serum IgE. We then sensitized mice with
10 mg of the immunodominant allergen
from the Dermatophagoides pteronyssinus
species of HDM, Der p 1, by intraperitoneal
injection on Days 22 and 30, followed
by challenge with 50 mg of Der p 1,
administered by oropharyngeal aspiration,
on Day 37. On Day 40, mice were killed,
followed by collection of blood and
whole-lung lavage fluid. After lavage,
lung tissue was snap frozen. Cytokines in
lavage fluid were measured using a multiplex
bead assay from Millipore (Billerica, MA).
Gene Expression Analysis and
eQTL Mapping
Total lung RNA was isolated from lung
tissue and then processed and hybridized
to Illumina WG-6v2 arrays (San Diego,
CA). Normalization was conducted using
robust multi-average normalization
with quantile normalization and log2
transformation. Array data have been
deposited to Gene Expression Omnibus
(GSE51768). eQTL mapping was
performed in essentially the same
fashion as QTL mapping, with some
modifications, as described in the
online supplement.
Quantitative RT-PCR
We measured gene expression of a long,
noncoding RNA (9030622O22Rik) in
preCC lung RNA samples using quantitative
RT-PCR with locked nucleic acid primers
designed by Exiqon (Woburn, MA) that
amplify one isoform of 9030622O22Rik,
ENSMUST00000136555. For
normalization, we measured the expression
of Rpl22 and calculated expression using
the delta Ct method (33).
Conditional Correlation Analysis
To identify eQTL that may underlie the
QTL for eosinophils, we used conditional
correlation. Specifically, we ran
chromosome (Chr) 11 QTL scans for
eosinophils or gene expression, with





eosinophils ¼ QTL1 gene expression1 e
Model 3 ðgene expressionÞ:
gene expression ¼ QTL1 e
Model 4 ðgene expressionjeosinophilsÞ:
gene expression ¼ QTL1 eosinophils1 e
A large drop in the logarithm of the
odds (LOD) score (“delta LOD”) between
models 1 and 2 provides evidence
to support a causal relationship
(QTL→gene expression→eosinophils)
(34). Conversely, a large LOD drop
between models 3 and 4 is indicative of
gene expression that is reactive to the
phenotype (i.e., QTL→eosinophils→gene
expression) (34). For these analyses, we
had complete data from 132 mice, and we
permuted the gene expression data (n =
1000 permutations) data to assess the




We employed longitudinal study design in
which preCC mice were phenotyped for
serum IgE before and after sensitization and
challenge with the HDM allergen Der p 1
at two different time points (“baseline”
and “final”). Total IgE increased over the
course of the experiment (Figure 1A), with
a mean increase (“delta IgE”) of 347 ng/ml
(P = 2.0 3 1024), demonstrating
expected effects of allergen sensitization
and challenge across the population.
Interestingly, having high baseline IgE
generally resulted in little or no increase
in antibody concentrations with
sensitization and challenge (Figure E1),
suggesting that IgE concentration has
a plateau value. Eosinophil counts in lung
lavage fluid spanned four orders of
magnitude (Figure 1B; range, 3.00 3
102 2 3.10 3 106; mean = 8.00 3 104),
demonstrating a wide range of responses
among the preCC population. Eosinophil
counts and final IgE were weakly
correlated (Figure 1C; Pearson’s r = 0.26,
P = 0.004), but there was no correlation
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between eosinophil counts and delta
IgE (Figure 1D). These results argue
against a predominant role for IgE
in inflammation in this model of
AAD. We did, however, detect very
strong correlations between eosinophils
and IL-4, -5, and -10 and eotaxin in
lavage fluid (Figures 1E and 1F), as
expected, based on the known role of
these cytokines in T helper type 2
inflammation.
Genetic Analyses
We conducted genome scans using the
preCC data and found a single QTL for
eosinophil counts on Chr 11 (Dpe1, Der
p 1–induced pulmonary eosinophils;
72.904–87.098 megabases [Mb], LOD = 7.0,
P , 0.05), as shown in Figure 2A. This
QTL accounted for 19% of total variation
in phenotype. We found a suggestive
peak (P , 0.2) for final IgE on Chr 11
(42.350–51.087 Mb, LOD = 6.2; Figure 2B)
that is distinct from the eosinophil
QTL. For delta IgE, we found one
significant QTL on Chr 4 (DsIgE,
13.950–31.660 Mb, LOD = 7.4;
Figure 2C), which explained 26%
of variation in delta IgE, and one
suggestive QTL (P , 0.1) on Chr 8
(119.086–122.313 Mb, LOD = 6.8). The
lack of overlap between QTL for IgE and
eosinophils further argues against
a major role for IgE in this model of
AAD. No QTL were detected for any of
the cytokines in lavage fluid.
We focused our subsequent analysis
on the eosinophil QTL with the goal
of identifying candidate genes. The
eosinophil QTL on Chr 11 spans 14.2 Mb
(72.9–87.1 Mb), and contains 359 genes,
252 of which are protein coding and 107 of
which are noncoding RNAs (see Table E1
in the online supplement). Among these
genes, Ccl11 (eotaxin) is the most
obvious candidate gene based on its known
role in eosinophil chemotaxis. We noted
that there is no coding region variation
in Ccl11 in CC founder strains, as
determined by sequencing data (24); thus,
if variation in Ccl11 underlies the
eosinophil QTL, the effect must be
mediated through mechanisms other
than variation in CCL11 protein
sequence variation.
We also asked whether syntenic regions
in the human genome contain genes
related to relevant phenotypes. The syntenic
regions in human genome lie on Chr 17p
Figure 1. Allergic airway disease (AAD) phenotypes in pre–Collaborative Cross (preCC) mice. (A) Serum IgE
before and after house dust mite (HDM) sensitization and challenge. A total of 12 mice had undetectable
IgE levels at the final time point. Each data point represents one mouse. (B) Eosinophil counts in lung
lavage fluid. (C–H) Pairwise correlations between traits. Dashed red lines represent linear best fit.
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and 17q, specifically 0–16.5 Mb, 25.5–28.9
Mb, 29.1–36.2 Mb, and 45.6–60.3 Mb. A
total of 94 genes in the mouse QTL have
human orthologs in these regions (Table
E2). Of these, CCL11 is the only gene
with prior evidence of association with
asthma or other allergic inflammation
phenotypes.
Gene Expression
We turned to gene expression as a way to
identify candidate genes for the eosinophil
QTL in an unbiased manner. We measured
gene expression in whole-lung samples
from 138 preCC mice and used these data
in two ways. First, we identified expressed
transcripts that were correlated with
eosinophils, so called quantitative trait
transcripts (QTTs) (30), by linear
regression. We identified 2,852 genes that
were correlated with eosinophil counts at
a false discovery rate of 5% (Table E3).
As expected, well known cytokines related
to AAD are in this list (e.g., Il4, Il10, and
Il33), as are genes previously associated
with asthma (e.g., Chi3l4) and genes
associated with mucous cell metaplasia
(e.g., Muc5ac, Spdef, and Foxa3). On the
whole, this set of QTTs is significantly
enriched for a number of immune
response pathways (Table E4). We also
found that this gene set is enriched
for genes associated with alternative
activation of macrophages (35) (Alox15,
Arg1, Ccl17, Ccl22, Ccl24, Ccr5, Chi3l1,
Clec7a, Col6a2, Fcer2a, Il10, Il1rn, Mertk,
Mgl2, Mmp12, Mrc1, Retnla, Retnlg, Rgs1,
Tgfb1; P = 6.47 3 1026), a pathway of
renewed interest in AAD (36). Hence,
it is apparent that this gene set reflects
contributions from both resident
lung cell types, such as airway
epithelia and infiltrating leukocytes
(e.g., macrophages).
We then used the gene expression data to
identify eQTL. As described in the online
supplement, we focused our eQTL analysis on
genes for which the expression array probe did
not contain single nucleotide polymorphisms
(SNPs), as these can bias eQTL detection (37,
38). Using these data, we identified 6,457
eQTL associated with 4,556 genes (Figure 3A,
Table E5). Of these eQTL, the large majority
(n = 4,759, 73.7%) were located on the
same chromosome as the cognate gene,
whereas 1,698 (26.3%) were located on other
chromosomes. The latter are indicative
of trans-regulatory variation (e.g.,
a polymorphic transcription factor located on
one chromosome that binds to the promoter
of a gene on another chromosome, and
are referred to as trans-eQTL).
We characterized eQTL located on
the same chromosome as the cognate gene in
terms of location relative to the corresponding
gene and effect size. In most cases, the eQTL
confidence intervals contain the cognate gene
(n = 4,065 out of 4,759 [85.4%], which
equates to 63% of all eQTL); hence, most
eQTL act in cis. Among cis-eQTL, there is an
intuitive relationship between LOD score and
distance to the gene–eQTL with the highest
LOD scores tending to be located close to the
gene (Figure E2). A small number of eQTL
(n = 228 [4.81% of eQTL located on the same
chromosome as cognate gene]) were located
further than 10 Mb away, and we categorized
these eQTL as trans-eQTL (see the online
supplement). Overall, our results suggest that
regulatory variation located close to genes is
a major source of eQTL in the lung.
Cis-eQTL were distributed genome
wide (Figure 3B), but trans-eQTL clustered
primarily into two hotspots (often referred
to as “trans-bands”) on Chr 2 (Figure 3C).
The existence of trans-bands on Chr 2
suggests that these loci harbor master
Figure 2. Genetic analysis of eosinophils and IgE. Genome scans for eosinophils (A), final IgE (B), and delta IgE (C). The dashed lines denote 95 and 80%
significance thresholds determined by permutation. LOD, logarithm of the odds.
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regulators of gene expression in the
allergen-challenged lung. Closer
examination of these two regions revealed
that each was dominated by a single locus.
Specifically, markers at 73.0 Mb and
147.6 Mb were associated with the
expression of 22 and 41 genes, respectively.
We also found that an additional 12 and 33
genes had trans-eQTL at a lower significance
Figure 3. Expression quantitative trait locus (eQTL) identification. (A) Genome-wide plot of eQTL (n = 6,457). (B) Distribution of cis-eQTL. (C) Distribution of
trans-eQTL. The y axis represents eQTL counts per 2-megabase (Mb) window.
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threshold of P less than 0.1 at these two
loci, respectively. In addition, when we
included probes that contain SNPs in this
analysis, these numbers increased to 51 and
102, respectively. We asked whether genes
with eQTL at these two loci on Chr 2 were
enriched among the set of eosinophil QTTs,
and found significant enrichment for genes
with trans-eQTL at the distal locus
(147.6 Mb, 1.5-fold enriched; P = 0.003), but
not for the more proximal locus (73.0 Mb;
P . 0.1). This focused our interest on the
distal locus as a potential regulator of
eosinophilic inflammation. We examined
the allele effects for all trans-eQTL at the
distal locus and found that, for the majority
of genes (95 out of 102 [93%]), gene
expression derived from A/J and C57BL/6J
alleles was different than expression derived
from the other six founder alleles. A
representative gene is shown in Figure 4A.
These eQTL allele effects suggested that A/J
and C57BL/6J share an allele that is distinct
from all other CC founder strains, and is
associated with altered gene expression. We
looked for a shared allele among these two
strains in the trans-band confidence interval
(Chr2: 146–150 Mb) using sequence data
(24) and identified a 53-kb interval spanning
147,807,490–147,860,365 bp in which these
two CC founder strains are 99.6% identical.
Phylogenetic analysis of this interval
shows that A/J and C57BL/6J share
a haplotype that is distinct from all other CC
founder strains (Figure 4B). A total of 68
SNPs in this region distinguish A/J and
C57BL/6J from all other CC founder strains,
and thus are potential causal variants for the
trans-band (Table E6). All 68 SNPs lie
within the putative long noncoding RNA
(lncRNA) 9030622O22Rik.
We then asked whether variation in
expression of this putative lncRNA could
underlie the trans-band. We measured the
expression level of one isoform of the
lncRNA (ENSMUST00000136555) using
quantitative RT-PCR and found that it had
an eQTL that overlapped with the region
on Chr 2 where A/J and C57BL/6J share
a haplotype (147,417,620–150,318,592 bp,
LOD = 11.45). We found that alleles
derived from A/J and C57BL/6J were also
associated with lower lncRNA eQTL
expression (Figure E3), but also that the
CAST/EiJ allele was associated with
relatively low lncRNA expression. Hence,
the allele effects for lncRNA eQTL and
genes in the trans-band are not fully
congruent. In addition, we examined
pairwise correlations between lncRNA
expression and the expression of genes in
the trans-band, and found no correlations.
Collectively, these results indicate
that, even though the lncRNA has
a colocalized eQTL, it is unlikely to be the
source of the trans-band, at least by
means of a direct relationship between its
expression and the expression of genes in
the trans-band.
Identification of Candidate Genes
for the Eosinophil QTL (Dpe1) Using
Gene Expression Data
Finally, we used our gene expression to
identify candidate genes for the eosinophil
QTL. Several studies have found that
variants associated with disease risk in
humans are often eQTL and imply that
disease risk is a function of variation in gene
expression, and one study used lung eQTL
to identify gene networks associated with
asthma (32). Therefore, we asked whether
lung eQTL could explain eosinophil
recruitment responses to allergen. First, we
identified genes that met two criteria: (1)
their expression was linearly correlated with
eosinophils (i.e., the gene is a QTT); and (2)
they had an eQTL within the eosinophil
QTL confidence interval (Chr 11:
72.904–87.098 Mb). A total of 18 genes met
these criteria: 2610507B11Rik, Atad5, Ccl11,
Figure 4. Fine mapping of a trans-band on Chr 2. (A) Allele effects plot for a representative gene in
the trans-band, Tusc2, showing separation of A/J and C57BL/6J allele effects from the other CC
founder strain alleles. Array-based measurements of Tusc2 expression from preCC mice partitioned
by their founder haplotype at the peak locus for the eQTL. For the sake of clarity, only homozygous
mice are shown (n = 99). Each data point represents a preCC mouse and plus symbols (1) represent
the means for each genotype. P , 0.05 for contrast between A/J. (B) Maximum likelihood
phylogenetic tree for the region of shared ancestry within the trans-band confidence interval. The tree
was constructed using single nucleotide polymorphism data from Sanger MGP Wellcome Trust
Sanger Mouse Genomes Project (see the online supplement), and the numbers indicate bootstrap
support estimates for each branch. Note that C57BL/6J and A/J haplotypes are separated by a short
branch (with 100% bootstrap support) from WSB/EiJ. This indicates that the number of genetic
variants that causes lower gene expression among CC mice with A/J or C57BL/6J haplotypes at this
locus is limited to a small number (n = 68; see Table E6). chr, chromosome.
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Ccl7, Coil, Inpp5k, Lig3, Mmp28, Poldip2,
Ppm1d, Ppm1e, Rpa1, Slc6a4, Ssh2, Supt4h1,
Tax1bp3, Tlcd1, and Tlcd2.
We then used conditional correlation to
evaluate whether the variation in expression
in any of these genes could underlie the
eosinophil QTL. Accounting for Ccl11
expression did not reduce the LOD score as
would be expected if there were a direct
relationship between the QTL, Ccl11
expression, and eosinophil recruitment. In
fact, the LOD score increased from 5.6 to 8.2
(P , 0.001, Table 1), which is indicative of
a more complex (indirect) relationship. We
found the greatest drop in the LOD score
was associated with the gene Tlcd2 (LOD
dropped from 5.6 to 3.1; P, 0.001; Table 1).
Because Tlcd2 expression was negatively
correlated with eosinophil counts (Table 1),
our results suggest that Tlcd2 is a candidate
negative regulator of eosinophil recruitment
responses to allergen.
Discussion
HDM sensitization and challenge produced
a wide range eosinophil recruitment
responses in preCC mice, and this diversity
facilitated the identification of a QTL for
eosinophil counts. It is interesting that
despite the fact the distribution of
eosinophil counts is suggestive of
a polygenic basis of inheritance in which
many loci contribute to the phenotype,
we only found one QTL associated with
eosinophil counts. Additional QTL may
be detectable with greater power, and the
availability of biological replicates for inbred
CC lines will facilitate this. In addition, we
detected significant changes in IgE over the
course of the experiment. However, these
changes were not correlatedwith eosinophilic
inflammation. These results are similar to
those of a human genome-wide association
study that detected loci associated with
asthma and loci associated with IgE, but
the two were not the same (14).
We identified a small set of priority
candidate genes for the eosinophil QTL by
merging the phenotype, gene expression,
and eQTL data. We tested whether the
expression of any single gene could underlie
eosinophil recruitment responses using
a simple linear model. Unexpectedly, we did
not find evidence for a direct relationship
between the QTL, Ccl11 (eotaxin)
expression, and eosinophil counts. Rather,
our results point to a more complex
relationship that opposes the direct effect
of Tlcd2, which we suggest is a novel
candidate gene. Tlcd2 is an intriguing
candidate gene in that TLC domain–
containing proteins are thought to act as
sphingolipid sensors (39) that are involved
in lung inflammation (40, 41), but little
else is known about this gene at present.
We did not observe changes in Tlcd2 gene
expression due to allergen sensitization
and challenge in our previous study (22),
nor is there evidence of differential
expression in other lung disease models for
which gene expression data is available in
National Center for Biotechnology
Information’s Gene Expression Omnibus
database. Thus the manner by which
variation in Tlcd2 gene expression affects
allergic inflammation is an important
question to address in future studies, as is
the question of which lung cell type(s)
express this gene.
We detected a large number of lung eQTL
(n = 6,457, corresponding to 4,556 genes).
This indicates that the expression of many











Tlcd2 380,712 NM_027249 ILMN_2814385 20.40 1.91E206 73.353 35.90 5.60 3.12 32.13
Tlcd2 380,712 NM_027249 ILMN_1249828 20.41 8.23E207 76.537 22.38 5.60 3.27 16.89
Tlcd2 380,712 NM_027249 ILMN_1213090 20.27 1.84E203 75.073 27.72 5.60 3.88 23.89
Ppm1d 53,892 NM_016910 ILMN_1226504 0.33 1.18E204 83.453 16.53 5.60 3.99 15.65
Mmp28 118,453 NM_172797 ILMN_1218211 20.24 5.00E203 83.408 16.24 5.60 4.17 14.06
Ccl7 20,306 NM_013654 ILMN_2835117 0.32 1.65E204 83.257 15.21 5.60 4.90 15.21
Tax1bp3 76,281 NM_029564 ILMN_2746086 20.26 2.89E203 73.353 10.57 5.60 4.97 10.42
Slc6a4 15,567 NM_010484 ILMN_2713714 20.26 2.90E203 75.265 17.94 5.60 4.99 17.27
Poldip2 67,811 NM_026389 ILMN_2543314 20.24 4.76E203 76.453 10.63 5.60 5.16 10.60
Supt4h1 20,922 NM_009296 ILMN_1247505 20.31 3.73E204 87.098 30.71 5.60 5.47 30.75
Ssh2 237,860 NM_177710 ILMN_1228331 20.24 4.78E203 83.444 10.37 5.60 5.49 10.24
Lig3 16,882 NM_010716 ILMN_1256377 0.33 8.96E205 82.222 6.87 5.60 5.52 8.60
Inpp5k 19,062 NM_008916 ILMN_2584558 20.33 1.41E204 73.872 9.76 5.60 5.53 9.98
2610507B11Rik 72,503 NM_001002004 ILMN_3014965 0.30 4.74E204 77.338 9.15 5.60 5.65 8.21
Coil 12,812 NM_016706 ILMN_2746210 20.25 3.89E203 84.286 11.46 5.60 5.65 11.51
Ccl7 20,306 NM_013654 ILMN_2771176 0.31 2.67E204 81.456 10.47 5.60 5.86 9.82
Tlcd1 68,385 NM_026708 ILMN_2781458 20.24 6.02E203 78.007 11.01 5.60 5.87 11.73
Ppm1e 32,0472 NM_177167 ILMN_2702374 0.30 4.33E204 83.474 10.67 5.60 5.99 11.44
Rpa1 68,275 NM_026653 ILMN_2750801 0.32 1.71E204 75.265 9.63 5.60 6.51 11.68
Atad5 237,877 NM_001029856 ILMN_2534259 0.38 5.94E206 81.302 18.06 5.60 7.21 19.12
Ccl11 20,292 NM_011330 ILMN_2647757 0.30 5.12E204 82.000 17.07 5.60 8.21 19.33
Definition of abbreviations: EOS, eosinophils; eQTL, expression quantitative trait locus; GEX, gene expression; LOD, logarithm of the odds; Mb, megabases.
*LOD score for EOS on chromosome 11. This analysis was based on complete data from 132 mice. In this population, the LOD score was 5.6 (versus 7.0
from the analysis of 151 mice with eosinophil data).
†See MATERIALS AND METHODS for description of conditional models.
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genes in the lung is controlled in part by
genetic variation. Based on our study design,
we cannot estimate what fraction of variation
in gene expression is due to allergen challenge
versus genetic variation or a combination
thereof (i.e., gene-by-HDM interactions). In
the future, it will be worthwhile to address
this, as well as categorizing eQTL by whether
they affect gene expression only in the naive/
unchallenged lung, only in the allergen-
challenged lung, or both (“dynamic” versus
“static” eQTL [43]). It will be particularly
interesting to investigate which type of eQTL
are more important in determining response
to allergen. Intuitively, we would expect that
the eQTL that regulate the induction/
repression of gene expression after allergen
challenge are more important, but this
hypothesis should be tested directly, as this
does not appear to be the case for Tlcd2 and
eosinophilia.
Whole lung is, of course, a
heterogeneous tissue, and contains
numerous cell types, particularly in the
context of AAD in which leukocytes
are recruited. This has both positive
and negative ramifications for eQTL
identification and characterization. On
the positive side, it is likely that we
detected many eQTL that would not have
been detected in naive or unchallenged
lung, because they are expressed in
infiltrating leukocytes. On the other hand,
identifying which specific cell type(s) is
the source of any particular eQTL remains
a significant challenge, but is crucial to
gaining further understanding of the
biology related to AAD.
One of the most interesting features
or our eQTL study was the identification
of numerous trans-eQTL. The relative
abundance of trans- versus cis-eQTL may
be a function of the allergen model, as
others have observed that trans-eQTL tend
be more common in models where an
environmental perturbation is applied (44).
We also found that trans-eQTL clustered to
specific genomic regions, most notably
a locus on Chr 2 that was associated with
expression of approximately 100 genes,
many of which were correlated with
eosinophil counts. We note, however, that
the locus on Chr 2 was not itself QTL for
eosinophil counts.
Some have expressed concern that
trans-bands may be an artifact of hidden
confounding in the data (45), but given
that we employed randomization
procedures to avoid such confounding, we
do not think this is the case for this locus.
We conducted post hoc analysis to test
whether potential confounders or batch
effects (RNA extraction date, hybridization
date, or enrichment of a particular
genotype and batch) could have resulted
in spurious associations, and found no
evidence of such biases. Based on the
consistent allele effects that we observed,
we narrowed the confidence interval
for the trans-band to a 53-kb region
containing a single gene, a putative
lncRNA. lncRNAs are known to regulate
gene expression, both in cis and in trans
(46), and affect lung phenotypes (42);
hence, we evaluated whether the lncRNA
could underlie the trans-band. Although
we found that this lncRNA also has an
eQTL at the same locus, its expression did
not correlate with genes in the trans-band,
and thus it appears unlikely that the
lncRNA explains the trans-band
exclusively through variation in
expression. It remains to be determined,
however, whether the 68 SNPs in this
putative lncRNA that distinguish A/J
and C57BL/6J alleles from the other
six CC founder alleles could give rise
to structurally different RNAs that
differentially control gene expression.
Alternatively, this locus may contain other
regulatory elements that control gene
expression in trans.
It is also interesting to note that the
trans-band on Chr 2 lies in a region that
appears to be a QTL hotspot for other
phenotypes. Previous studies have found
QTL in this region for metabolism-
related phenotypes, including blood
glucose level (47), plasma levels of sterol
(48), and growth and body fat parameters
(49, 50). In addition, QTL for immune-
related phenotypes, including natural
killer T cell number in the thymus (51),
experimentally induced induced colitis
(52), and chemically induced bladder
tumorigenesis (53), also map to this
locus. It will be interesting to see whether
the genes with trans-eQTL at this locus
may be related to those phenotypes. A
QTL for bronchial hyperresponsiveness
also contained this locus (54). However,
the bronchial hyperresponsiveness QTL
was identified using C57BL/6J and A/J
strains, the two strains that share
a haplotype at the locus that we
identified. Therefore, the trans-band
locus cannot explain the bronchial
hyperresponsiveness QTL.
In summary, we used a genetically
diverse mouse population to quantify
correlations between AAD phenotypes and
identify genetic loci that control AAD
phenotypes, including gene expression
in the lung. We identified a candidate gene
for eosinophilic inflammation caused by
HDM using the gene expression data.
Finally, our eQTL data also provide insights
about gene regulation in the context of
allergen challenge. n
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